JOINT FILING AGREEMENT
Exhibit 99.9
THIS JOINT FILING AGREEMENT is entered into as of May 15, 2013, by and among the parties hereto. The undersigned hereby agree that the Statement on the amendment to the Schedule 13D with respect to the common stock, par value $0.0001 per share (the “Common Stock”) of China Biologic Products, Inc., to which this agreement is attached as an exhibit, and any amendment thereafter signed by each of the undersigned shall be (unless otherwise determined by the undersigned) filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
| Dated: May 15, 2013 | WP X Biologics LLC | |||||
| By: Warburg Pincus Private Equity X, L.P., its managing member By: Warburg Pincus X, L.P., its general partner | ||||||
| By: Warburg Pincus X LLC, its general partner | ||||||
| By: Warburg Pincus Partners LLC, its sole member | ||||||
| By: Warburg Pincus & Co., its managing member | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Attorney-in-Fact* | |||||
| WARBURG PINCUS PRIVATE EQUITY X, L.P. | ||||||
| By: Warburg Pincus X, L.P., its general partner | ||||||
| By: Warburg Pincus X LLC, its general partner | ||||||
| By: Warburg Pincus Partners LLC, its sole member | ||||||
| By: Warburg Pincus & Co., its managing member | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Attorney-in-Fact* | |||||
| WARBURG PINCUS X PARTNERS, L.P. | ||||||
| By: Warburg Pincus X, L.P., its general partner | ||||||
| By: Warburg Pincus X LLC, its general partner | ||||||
| By: Warburg Pincus Partners LLC, its sole member | ||||||
| By: Warburg Pincus & Co., its managing member | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Attorney-in-Fact* | |||||
-1-
| WARBURG PINCUS X, L.P. | ||||||
| By: Warburg Pincus X LLC, its general partner | ||||||
| By: Warburg Pincus Partners LLC, its sole member | ||||||
| By: Warburg Pincus & Co., its managing member | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Attorney-in-Fact* | |||||
| WARBURG PINCUS X LLC | ||||||
| By: Warburg Pincus Partners LLC, its sole member | ||||||
| By: Warburg Pincus & Co., its managing member | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Attorney-in-Fact* | |||||
| WARBURG PINCUS PARTNERS LLC | ||||||
| By: Warburg Pincus & Co., its managing member | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Attorney-in-Fact* | |||||
| WARBURG PINCUS & CO. | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Attorney-in-Fact* | |||||
| WARBURG PINCUS LLC | ||||||
| By: | /s/ Xxxxx X. Xxxxxxx | |||||
| Name: | Xxxxx X. Xxxxxxx | |||||
| Title: | Managing Director | |||||
-2-
| XXXXXXX X. XXXX | ||||||
| By: | /s/ Xxxxxxx X. Xxxx | |||||
| Name: | Xxxxxxx X. Xxxx | |||||
| By: | Xxxxx X. Xxxxxxx, Attorney-in-Fact* | |||||
| XXXXXX X. XXXXX | ||||||
| By: | /s/ Xxxxxx X. Xxxxx | |||||
| Name: | Xxxxxx X. Xxxxx | |||||
| By: | Xxxxx X. Xxxxxxx, Attorney-in-Fact* | |||||
| * | The Power of Attorney given by each of Warburg Pincus & Co., Xx. Xxxx and Xx. Xxxxx was previously filed with the U.S. Securities & Exchange Commission on January 15, 2013 as an exhibit to a statement on Schedule 13D/A filed by Warburg Pincus Private Equity X, L.P. with respect to Talon Therapeutics, Inc. and is hereby incorporated by reference. |
-3-
